Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 49
Thursday, April 6, 2017, 11:04 a.m. to 12:51 p.m.
Televised
Presiding
Bill Casey, Chair (Liberal)

Library of Parliament
• Karin Phillips, Analyst
• Hon. Jane Philpott, P.C., M.P., Minister of Health
Canadian Food Inspection Agency
• Paul Glover, President
Canadian Institutes of Health Research
• Michel Perron, Vice-President, External Affairs and Business Development
Department of Health
• Simon Kennedy, Deputy Minister
Public Health Agency of Canada
• Siddika Mithani, President
• Theresa Tam, Interim Chief Public Health Officer
Pursuant to Standing Order 81(4), the Committee commenced consideration of the Main Estimates 2017-18: Votes 1 and 5 under Canadian Food Inspection Agency, Votes 1 and 5 under Canadian Institutes of Health Research, Votes 1, 5 and 10 under Department of Health, Vote 1 under Patented Medicine Prices Review Board and Votes 1, 5 and 10 under Public Health Agency of Canada, referred to the Committee on Thursday, February 23, 2017.

The Chair called Vote 1 under Canadian Food Inspection Agency.

The minister made a statement and, with Paul Glover, Michel Perron, Simon Kennedy and Theresa Tam, answered questions.

The Committee proceeded to the consideration of matters related to Committee business.

On motion of Colin Carrie, it was agreed, — That, in relation to the study on thalidomide, the members of the Committee submit to the Clerk of the Committee, by Friday, April 7, 2017, by the end of the day, their lists of witnesses.

At 12:51 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee